28.03.2014 • NewsDede WillamsEniR&D

Versalis to Invest €125 Million in Mantova Plant

Italian energy giant Eni and its chemicals subsidiary Versalis plan to invest €125 million at Versalis' production site in Mantova, Italy.

Eni said the investment is part of its four-year strategic plan for the period 2014-2017 that foresees optimizing production processes and generating additional energy savings as well as expanding research and development.

The companies did not specify what the upgrade would entail, other than pointing to "strong business opportunities relating to production of intermediates and styrenics, including styrene, polystyrene and styrene-acrylonitrile.

R&D facilities at Mantova are grouped around the Claudio Buonera Research Center which employs 200 people and focuses on basic chemistry and plastics. Altogether, the workforce at the site totals 962

Earlier this year, Versalis announced it would conduct a €200 million revamp of its Porto Marghera site, which would require shutting down production of olefins and aromatics for six months from the end of February.

The company said the Marghera shutdown would not affect other sites. The company also has production facilities at Ravenna, Italy.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.